Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.65 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.65 |
| ▸ | TACR2 | P21452 | 2/20 | 0.65 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | ACHE | P22303 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | SHBG | P04278 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.65 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.65 |
| ▸ | HTR2C | P28335 | 1/20 | 0.65 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | TST | Q16762 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10405809 | 1.00 | ESR1 (0.65) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL8055358 | 1.00 | ESR1 (0.65) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL26331386 | 1.00 | ESR1 (0.65) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL1070427 | 1.00 | ESR1 (0.65) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL11228648 | 1.00 | ESR1 (0.65) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL1172078 | 0.98 | CA2 (0.68) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL274830 | 0.90 | CA2 (0.71) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL23837668 | 0.90 | CA2 (0.63) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL9165397 | 0.90 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL7784766 | 0.90 | ESR1 (0.77) | ESR1ADRA2ASLC6A2ADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240110130-A1 | COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-04-04 | — | — | US | claimed |
| EP-4281530-A1 | COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-11-29 | — | — | EP | claimed |
| CN-116761874-A | Composition and method for producing the same | 联合利华知识产权控股有限公司 | 2023-09-15 | — | — | CN | claimed |
| WO-2022157232-A1 | COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-07-28 | — | — | WO | claimed |
| US-20240110130-A1 | COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-04-04 | — | — | US | disclosed |
| EP-4281530-A1 | COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-11-29 | — | — | EP | disclosed |
| CN-113574041-B | Bisphenol production method and polycarbonate resin production method | 三菱化学株式会社 | 2023-10-13 | — | — | CN | disclosed |
| CN-116761874-A | Composition and method for producing the same | 联合利华知识产权控股有限公司 | 2023-09-15 | — | — | CN | disclosed |
| WO-2022157232-A1 | COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-07-28 | — | — | WO | disclosed |
| CN-109988213-B | Compound for polypeptide liquid phase synthesis carrier and preparation method and application thereof | 深圳翰宇药业股份有限公司 | 2021-09-17 | — | — | CN | disclosed |
| EP-2790728-B1 | TOPICAL PHARMACEUTICAL COMPOSITIONS OF THIOCOLCHICOSIDE AND METHYLSULFONYLMETHANE | SANOVEL ILAC SANAYI VE TICARET (TR) | 2015-08-19 | — | — | EP | disclosed |
| WO-2014184173-A1 | HAIR CARE FORMULATIONS | MONTERO GIDA SANAYI VE TICARET A.S. (TR) | 2014-11-20 | — | — | WO | disclosed |
| EP-0485045-B1 | Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them | SCHERING AG (DE) | 1998-12-30 | — | — | EP | disclosed |
| EP-0625981-A1 | AZABICYCLO COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1994-11-30 | — | — | EP | disclosed |
| US-5277895-A | Nuclear magnetic resonance | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-01-11 | — | — | US | disclosed |
| WO-1993015080-A1 | AZABICYCLO COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1993-08-05 | — | — | WO | disclosed |
| EP-0485045-A2 | Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-05-13 | — | — | EP | disclosed |
| EP-0398578-A2 | 2-piperidino-1-alkanol derivatives as antiischemic agents | PFIZER INC. (US) | 1990-11-22 | — | — | EP | disclosed |
| EP-0160258-B1 | (6,11-DIHYDRO-11-OXODIBENZ(BM,E)OXEPINYL)PENTANOLS, A PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-09-27 | — | — | EP | disclosed |
| EP-0160258-A2 | (6,11-Dihydro-11-oxodibenz(bm,e)oxepinyl)pentanols, a process and intermediates for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1985-11-06 | — | — | EP | disclosed |